0001567619-21-016263.txt : 20210824 0001567619-21-016263.hdr.sgml : 20210824 20210824115054 ACCESSION NUMBER: 0001567619-21-016263 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210819 FILED AS OF DATE: 20210824 DATE AS OF CHANGE: 20210824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zhen Marianne CENTRAL INDEX KEY: 0001750085 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 211200481 MAIL ADDRESS: STREET 1: C/O INNOVIVA, INC. STREET 2: 2000 SIERRA POINT PARKWAY, SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc. CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 6502389600 MAIL ADDRESS: STREET 1: 1350 OLD BAYSHORE HIGHWAY STREET 2: SUITE 400 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: THERAVANCE INC DATE OF NAME CHANGE: 20020207 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 4/A 1 doc1.xml FORM 4/A X0306 4/A 2021-08-19 2021-08-23 0 0001080014 Innoviva, Inc. INVA 0001750085 Zhen Marianne 1350 OLD BAYSHORE HIGHWAY, SUITE 400 BURLINGAME CA 94010 0 1 0 0 Chief Accounting Officer Common Stock 2021-08-20 4 S 0 1129 15.89 D 35364 D The Form 4 of the Reporting Person filed with the Securities and Exchange Commission on August 23, 2021 inadvertently indicated in Column 4 of Table I that the sale by the Reporting Person of 1,129 shares of Common Stock of the Issuer on August 20, 2021 was an acquisition "(A)" rather than a disposition "(D)". For the avoidance of doubt, such sale transaction was a disposition "(D)". /s/ Marianne Zhen 2021-08-24